Brain Injuries, Traumatic
144
15
23
74
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
15 trials with published results (10%)
Research Maturity
74 completed trials (51% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.9%
7 terminated out of 144 trials
91.4%
+4.8% vs benchmark
6%
8 trials in Phase 3/4
20%
15 of 74 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 74 completed trials
Clinical Trials (144)
Early Redox Biomarker Changes After Stellate Ganglion Block in Traumatic Brain Injury
Critical Hyperacute Assessment Research On Neurobiomarker Kinetics in Acute Brain Injury
ZEPU-AI Series Limb Feedback Robot Training Study (ZEPUAISRCT)
Head and Intraocular Trauma Tool for the Identification of Mild Traumatic Brain Injury
HITT for the Identification of Mild Traumatic Brain Injury
Multimodal Assessment and Prognosis in Disorders of Consciousness After Severe Brain Injury (CyDoC-MAP)
GOALS Cognitive Training Delivered to Aging Veterans in Person or Via Telehealth
Wellness and Quality of Life Perceptions of People With Traumatic Brain Injury
The HOME Program for Individuals With Traumatic Brain Injury and Family Members
Socio-Cultural Level, Health Literacy, and Parental CT Demand in Paediatric Minor Head Trauma
Proteomics of Brain Trauma-associated Elevated Intracranial Pressure (ICP)
Scale-Up Evaluation Trial of the Diabetes Prevention Program to Improve Obesity and Cardiometabolic Health After Traumatic Brain Injury
Automated Robotic TCD in Traumatic Brain Injury
The DIAGNOSE CTE Research Project-II
Light Therapy to Improve Sleep in TBI: Sleep-active Biomarkers and Glymphatic Function
mTBI Identification and Monitoring Through Retinal Scanning
Prospective Observational Multimodal Neuromonitoring in Adult NSICU Patients
Buspirone and Melatonin for Depression Following Traumatic Brain Injury
Mild TBI Assessment & Rehabilitation
Brain Oxygen Optimization in Severe TBI, Phase 3